PRINTER'S NO. 3991

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 2933 Session of 1992


        INTRODUCED BY BARLEY, FARGO, ULIANA, VROON, LAWLESS, NOYE,
           NICKOL, BOYES, BELFANTI, ADOLPH, SCHEETZ, PHILLIPS, WOGAN,
           KENNEY, DEMPSEY, TOMLINSON, JOHNSON, M. N. WRIGHT, CLARK,
           TIGUE, E. Z. TAYLOR, STABACK, DeLUCA, ARMSTRONG, CLYMER, LEH,
           HERSHEY, OLASZ, BILLOW, LEVDANSKY, BUNT, PETRONE, O'BRIEN,
           CIVERA, FAIRCHILD, STAIRS, SAURMAN, KREBS, TRELLO, COLAFELLA,
           LANGTRY AND RUDY, SEPTEMBER 22, 1992

        REFERRED TO COMMITTEE ON HEALTH AND WELFARE, SEPTEMBER 22, 1992

                                     AN ACT

     1  Amending the act of November 29, 1990 (P.L.585, No.148),
     2     entitled "An act providing for confidentiality of certain
     3     records; providing for the authorized sharing of certain
     4     information; providing for written consent prior to an HIV-
     5     related test, with certain exceptions; providing for civil
     6     immunity for certain licensed physicians; providing for
     7     protective procedures and equipment; and creating a civil
     8     cause of action," further providing for intent and consent to
     9     testing; and making repeals.

    10     The General Assembly of the Commonwealth of Pennsylvania
    11  hereby enacts as follows:
    12     Section 1.  Section 2(c) of the act of November 29, 1990
    13  (P.L.585, No.148), known as the Confidentiality of HIV-Related
    14  Information Act, is amended to read:
    15  Section 2.  Legislative intent.
    16     * * *
    17     (c)  Intent.--[It is the intent of the General Assembly to
    18  promote confidential testing on an informed and voluntary basis
    19  in order to encourage those most in need to obtain testing and

     1  appropriate counseling.] It is the intent of the General
     2  Assembly to provide for the confidentiality of HIV-related
     3  information in order to encourage those at risk to obtain
     4  testing and treatment. It is the further intent to allow
     5  physician testing for HIV under the same circumstances
     6  physicians would test for other communicable diseases in order
     7  to encourage early detection, treatment and prevention.
     8     * * *
     9     Section 2.  The definitions of "first responder,"
    10  "significant exposure" and "source patient" in section 3 of the
    11  act are repealed.
    12     Section 3.  Section 5 of the act is amended to read:
    13  Section 5.  Consent to HIV-related test.
    14     [(a)  Consent.--Except as provided in section 6 with respect
    15  to the involuntary testing of a source patient, no HIV-related
    16  test shall be performed without first obtaining the informed
    17  written consent of the subject. Any consent shall be preceded by
    18  an explanation of the test, including its purpose, potential
    19  uses, limitations and the meaning of its results.
    20     (b)  Pretest counseling.--No HIV-related test may be
    21  performed without first making available to the subject
    22  information regarding measures for the prevention of, exposure
    23  to and transmission of HIV.
    24     (c)  Confirmatory test.--No test result shall be determined
    25  as positive, and no positive test result shall be revealed,
    26  without confirmatory testing if it is required by generally
    27  accepted medical standards.
    28     (d)  Notice of test result.--The physician who ordered the
    29  test, the physician's designee or a successor in the same
    30  relationship to the subject shall make a good faith effort to
    19920H2933B3991                  - 2 -

     1  inform the subject of the result regardless of whether the
     2  result is positive or negative.
     3     (e)  Post-test counseling.--
     4         (1)  No positive or negative test result shall be
     5     revealed to the subject without affording the subject the
     6     immediate opportunity for individual, face-to-face counseling
     7     about:
     8             (i)  The significance of the test results.
     9             (ii)  Measures for the prevention of the transmission
    10         of HIV.
    11             (iii)  The benefits of locating and counseling any
    12         individual by whom the subject may have been exposed to
    13         HIV and the availability of any services with respect to
    14         locating and counseling such individual.
    15         (2)  No positive test result shall be revealed to the
    16     subject without, in addition to meeting the requirements of
    17     paragraph (1), also affording the subject the immediate
    18     opportunity for individual, face-to-face counseling about:
    19             (i)  The availability of any appropriate health care
    20         services, including mental health care, and appropriate
    21         social and support services.
    22             (ii)  The benefits of locating and counseling any
    23         individual who the infected subject may have exposed to
    24         HIV and the availability of any services with respect to
    25         locating and counseling such individual.
    26     (f)  Blinded HIV-related testing.--Blinded HIV-related
    27  testing for purposes of research performed in a manner by which
    28  the identity of the test subject is not known and may not be
    29  retrieved by the researcher is prohibited, unless reviewed and
    30  approved by the institutional review board established by the
    19920H2933B3991                  - 3 -

     1  department except for testing pursuant to research approved by
     2  an institutional review board prior to the effective date of
     3  this act. The department shall make a good faith effort to
     4  maintain records of the results of blinded HIV tests performed
     5  in this Commonwealth and shall, on a yearly basis, forward
     6  information concerning the results to the appropriate committees
     7  of the General Assembly.
     8     (g)  Exceptions.--
     9         (1)  The provisions of subsections (a), (b), (c), (d) and
    10     (e) shall not apply to the following:
    11             (i)  The performance of an HIV-related test on a
    12         cadaver by a health care provider which procures,
    13         processes, distributes or uses a human body or a human
    14         body part, tissue or semen for use in medical research,
    15         therapy or transplantation.
    16             (ii)  The performance of an HIV-related test for the
    17         purpose of medical research not prohibited by subsection
    18         (f) if the testing is performed in a manner by which the
    19         identity of the test subject is not known and may not be
    20         retrieved by the researcher.
    21             (iii)  The performance of an HIV-related test when
    22         the test result of a subject is required by an insurer
    23         for underwriting purposes. However, the insurer shall
    24         satisfy the requirements of subsection (h).
    25         (2)  The provisions of subsections (a), (b) and (c) shall
    26     not apply to the performance of an HIV-related test in a
    27     medical emergency when the subject of the test is unable to
    28     grant or withhold consent and the test result is medically
    29     necessary for diagnostic purposes to provide appropriate
    30     emergency care to the subject.
    19920H2933B3991                  - 4 -

     1         (3)  The provisions of subsections (d) and (e) shall not
     2     apply when a negative HIV-related test result is secured by a
     3     subject who has taken the test solely to satisfy a
     4     requirement for donating a human body or human body part,
     5     tissue or semen for use in medical research, therapy,
     6     transfusion or transplantation. However, if the subject
     7     requests identification of a negative test result, the test
     8     result shall be provided to the subject in accordance with
     9     subsection (d).
    10     (h)  Requirements applicable to insurers.--
    11         (1)  No HIV-related test shall be performed without first
    12     obtaining the informed written consent of the subject. Any
    13     consent shall be preceded, in writing, by:
    14             (i)  A disclosure of the effects of the test result
    15         on the approval of the application, or the risk
    16         classification of the subject.
    17             (ii)  Information explaining AIDS, HIV and the HIV-
    18         related test.
    19             (iii)  A description of the insurer's confidentiality
    20         standards.
    21             (iv)  A statement that, because of the serious nature
    22         of HIV-related illnesses, the subject may desire to
    23         obtain counseling before undergoing the HIV-related test.
    24             (v)  Information concerning the availability of
    25         alternative HIV-related testing and counseling provided
    26         by the department and local health departments, and the
    27         telephone number of the department from which the subject
    28         may secure additional information on such testing and
    29         counseling.
    30         (2)  The insurer is required to disclose to the subject a
    19920H2933B3991                  - 5 -

     1     negative test result on an HIV-related test only if the
     2     subject requests notification.
     3         (3)  The insurer shall not disclose to the subject of an
     4     HIV-related test a positive test result. On the form on which
     5     the insurer secures the subject's written consent to the HIV-
     6     related test, the subject shall be required to designate to
     7     whom a positive test result shall be disclosed. The subject
     8     shall have the choice of designating a physician, the
     9     department or a local health department, or a local
    10     community-based organization from a list of such
    11     organizations prepared by the department. The insurer shall
    12     notify the designee of a positive test result.
    13         (4)  A positive test result shall be disclosed to the
    14     subject, by the designee, in accordance with subsections (d)
    15     and (e). The department may elect to have its disclosure
    16     responsibilities satisfied by a local health department.]
    17     (a)  Consent requirements applicable to insurers.--
    18         (1)  No HIV-related test shall be performed without first
    19     obtaining the informed written consent of the subject. Any
    20     consent shall be preceded in writing by:
    21             (i)  A disclosure of the effects of the test result
    22         on the approval of the application, or the risk
    23         classification of the subject.
    24             (ii)  Information explaining aids, HIV and the HIV-
    25         related test.
    26             (iii)  A description of the insurer's confidentiality
    27         standards.
    28             (iv)  A statement that, because of the serious nature
    29         of HIV-related illnesses, the subject may desire to
    30         obtain counseling before undergoing the HIV-related test.
    19920H2933B3991                  - 6 -

     1             (v)  Information concerning the availability of
     2         alternative HIV-related testing and counseling provided
     3         by the department and local health departments, and the
     4         telephone number of the department from which the subject
     5         may secure additional information on such testing and
     6         counseling.
     7         (2)  The insurer is required to disclose to the subject a
     8     negative test result on an HIV-related test only if the
     9     subject requests notification.
    10         (3)  The insurer shall not disclose to the subject of an
    11     HIV-related test a positive test result. On the form on which
    12     the insurer secures the subject's written consent to the HIV-
    13     related test, the subject shall be required to designate to
    14     whom a positive test result shall be disclosed. The subject
    15     shall have the choice of designating a physician, the
    16     department or a local health department, or a local
    17     community-based organization from a list of such
    18     organizations prepared by the department. The insurer shall
    19     notify the designee of a positive test result.
    20     (b)  Consent requirements applicable to physicians.--A
    21  physician involved in the care of a patient who concludes in his
    22  reasonable medical judgment that a blood test is appropriate for
    23  the care of the patient, the protection of the public or of
    24  health care workers may perform or order an HIV test and the
    25  informed consent of the patient shall be deemed given.
    26     Section 4.  Section 6 of the act is repealed.
    27     Section 5.  This act shall take effect in 60 days.


    F15L35JLW/19920H2933B3991        - 7 -